Health Care & Life Sciences » Biotechnology | TetraLogic Pharmaceuticals Corp.

TetraLogic Pharmaceuticals Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Cash & Short Term Investments
15,552.00
51,874.70
55,155.50
53,697.50
20,409.00
Other Current Assets
445.80
129.00
153.20
1,784.10
1,561.70
Total Current Assets
15,997.80
52,003.70
55,308.70
55,481.60
21,970.70
Net Property, Plant & Equipment
296.90
171.90
139.60
528.50
417.80
Intangible Assets
-
-
-
58,478.00
41,575.50
Other Assets
54.10
54.10
54.10
3,803.00
57.30
Total Assets
16,348.90
52,229.70
55,502.40
118,291.00
64,021.40
Accounts Payable
833.60
1,145.10
1,215.20
1,138.50
-
Other Current Liabilities
2,656.10
1,978.90
3,715.20
3,983.80
3,659.70
Total Current Liabilities
3,489.70
3,124.10
4,930.40
5,122.30
3,659.70
Long-Term Debt
-
-
-
28,979.30
28,278.90
Deferred Taxes
-
-
-
16,879.70
16,879.70
Other Liabilities
35.30
30.00
23.00
33,907.60
21,143.80
Total Liabilities
3,525.00
3,154.10
4,953.40
84,888.90
69,962.10
Common Equity (Total)
52,588.40
49,075.60
50,549.10
33,402.20
5,940.70
Total Shareholders' Equity
12,823.80
49,075.60
50,549.10
33,402.20
5,940.70
Total Equity
12,823.80
49,075.60
50,549.10
33,402.20
5,940.70
Liabilities & Shareholders' Equity
16,348.90
52,229.70
55,502.40
118,291.00
64,021.40
Preferred Stock (Carrying Value)
65,412.20
-
-
-
-

About TetraLogic Pharmaceuticals

View Profile
Address
343 Phoenixville Pike
Malvern Pennsylvania 19355
United States
Employees -
Website http://www.tetralogicpharma.com
Updated 07/08/2019
TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. It products include Birinapant, and SHAPE. The company was founded by John M.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.